- Home
- GEHC vs CTVA Comparison
GEHC vs CTVA Comparison
Compare GEHC & CTVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GEHC | CTVA |
|---|---|---|
| Founded | 1892 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Farming/Seeds/Milling |
| Sector | Technology | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.9B | 44.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GEHC | CTVA |
|---|---|---|
| Price | $81.53 | $69.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 17 |
| Target Price | ★ $88.27 | $78.38 |
| AVG Volume (30 Days) | 2.9M | ★ 3.2M |
| Earning Date | 02-04-2026 | 02-03-2026 |
| Dividend Yield | 0.17% | ★ 1.03% |
| EPS Growth | 32.35 | ★ 139.00 |
| EPS | ★ 4.83 | 2.35 |
| Revenue | ★ $20,246,000,000.00 | $17,469,000,000.00 |
| Revenue This Year | $6.33 | $6.91 |
| Revenue Next Year | $4.32 | $3.50 |
| P/E Ratio | ★ $16.92 | $28.32 |
| Revenue Growth | 3.51 | ★ 5.00 |
| 52 Week Low | $57.65 | $53.40 |
| 52 Week High | $94.80 | $77.41 |
Technical Indicators
Market Signals| Indicator | GEHC | CTVA |
|---|---|---|
| Relative Strength Index (RSI) | 43.84 | 60.94 |
| Support Level | $84.59 | $67.93 |
| Resistance Level | $87.60 | $70.87 |
| Average True Range (ATR) | 2.20 | 1.40 |
| MACD | -0.55 | 0.14 |
| Stochastic Oscillator | 4.64 | 77.31 |
Price Performance
Historical ComparisonAbout GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
About CTVA Corteva Inc.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva plans to spin off its seeds business in 2026 and will become a pure-play crop protection company following the divestiture. Corteva operates globally, but around half of revenue comes from North America.